Entero Therapeutics, Inc.
FWBI
Revenue
0.00
0.000.00%
12 Months ChangeAssets
86.29M
▼-4.85M▼-5.32%
3 Months ChangeLiabilities
15.49M
▲2.22M▲16.70%
3 Months ChangeFree Cash Flow
-5.07M
▼-3.78M▼-291.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-20
Form 8-K
ID: 0001104659-24-073418
2024-06-05
Form 8-K
ID: 0001104659-24-068733
2024-05-16
Form 8-K
ID: 0001104659-24-062263
2024-05-14
Form 10-Q
ID: 0001410578-24-000826
2024-05-13
Form 8-K
ID: 0001104659-24-060689
2024-03-22
Form 8-K
ID: 0001104659-24-037932
2024-03-18
Form 8-K
ID: 0001104659-24-035598
2024-03-14
Form 8-K
ID: 0001104659-24-034161
2024-03-05
Form 8-K
ID: 0001104659-24-031098
2024-01-04
Form 8-K
ID: 0001104659-24-001157